Abstract
Background: 5-fluorouracil and resveratrol are the two most effective anticancer drugs. Combination therapy with these two drugs has shown promising results in cancer. The formulation containing 5-fluorouracil and resveratrol has been prepared, but no analytical method is available in the literature for their simultaneous estimation. However, several analytical methods are there for estimation of either 5-fluorouracil or resveratrol alone. Therefore, the present article is designed for the simultaneous estimation of 5-fluorouracil and resveratrol by HPLC and its application in the quantification of the drugs present in the formulated nanostructured lipid carrier (NLC).
Methods: The method was developed using a C18 column (Purospher® STAR RP-18 endcapped (5 μm) Hibar® RT 250-4.6) with acetonitrile and water as the mobile phase (25:75 v/v) and estimated at 272 nm. The currently developed method was further validated by the ICH guideline Q2 (R1). Combinatorial NLC of 5-fluorouracil and resveratrol was also prepared and characterized.
Results: The LOD and LOQ were 8.22 and 24.91 μg mL-1 and 6.58 and 19.93 μg mL-1, respectively. The precision was under the acceptable limits of <2% RSD. The content of 5-fluorouracil and resveratrol in NLC were found to be 99.452% and 96.421%, respectively.
Conclusion: The findings showed that the developed and validated method was simple, fast, costeffective, and reproducible for the simultaneous estimation of both the drugs in the same formulation.
Keywords: Compatibility, forced degradation, ICH guideline Q2 (R1), isosbestic point, simultaneous determination, stability indicating.
Graphical Abstract
[1]
Fernandes, A.R.; Santos, A.C.; Sanchez-Lopez, E.; Kovačević, A.B.; Espina, M.; Calpena, A.C.; Veiga, F.J.; Garcia, M.L.; Souto, E.B. Neoplastic multifocal skin lesions: Biology, etiology, and targeted therapies for nonmelanoma skin cancers. Skin Pharmacol. Physiol., 2018, 31(2), 59-73.
[http://dx.doi.org/10.1159/000479529] [PMID: 29262420]
[http://dx.doi.org/10.1159/000479529] [PMID: 29262420]
[2]
Ser, Z.; Gao, X.; Johnson, C.; Mehrmohamadi, M.; Liu, X.; Li, S.; Locasale, J.W. Targeting one carbon metabolism with an antimetabolite disrupts pyrimidine homeostasis and induces nucleotide overflow. Cell Rep., 2016, 15(11), 2367-2376.
[http://dx.doi.org/10.1016/j.celrep.2016.05.035] [PMID: 27264180]
[http://dx.doi.org/10.1016/j.celrep.2016.05.035] [PMID: 27264180]
[3]
Ndiaye, M.; Philippe, C.; Mukhtar, H.; Ahmad, N. The grape antioxidant resveratrol for skin disorders: Promise, prospects, and challenges. Arch. Biochem. Biophys., 2011, 508(2), 164-170.
[http://dx.doi.org/10.1016/j.abb.2010.12.030] [PMID: 21215251]
[http://dx.doi.org/10.1016/j.abb.2010.12.030] [PMID: 21215251]
[4]
Burns, J.; Yokota, T.; Ashihara, H.; Lean, M.E.; Crozier, A. Plant foods and herbal sources of resveratrol. J. Agric. Food Chem., 2002, 50(11), 3337-3340.
[http://dx.doi.org/10.1021/jf0112973] [PMID: 12010007]
[http://dx.doi.org/10.1021/jf0112973] [PMID: 12010007]
[5]
Ogas, T.; Kondratyuk, T.P.; Pezzuto, J.M. Resveratrol analogs: Promising chemopreventive agents. Ann. N. Y. Acad. Sci., 2013, 1290, 21-29.
[http://dx.doi.org/10.1111/nyas.12196] [PMID: 23855462]
[http://dx.doi.org/10.1111/nyas.12196] [PMID: 23855462]
[6]
Vitale, N.; Kisslinger, A.; Paladino, S.; Procaccini, C.; Matarese, G.; Pierantoni, G.M.; Mancini, F.P.; Tramontano, D. Resveratrol couples apoptosis with autophagy in UVB-irradiated HaCaT cells. PLoS One, 2013, 8, 1-13.
[7]
Losada-Barreiro, S.; Costa, M.; Bravo-Díaz, C.; Paiva-Martins, F. Distribution and antioxidant efficiency of resveratrol in stripped corn oil emulsions. Antioxidants, 2014, 3(2), 212-228.
[http://dx.doi.org/10.3390/antiox3020212] [PMID: 26784868]
[http://dx.doi.org/10.3390/antiox3020212] [PMID: 26784868]
[8]
Santos, A.C.; Veiga, F.; Ribeiro, A.J. New delivery systems to improve the bioavailability of resveratrol. Expert Opin. Drug Deliv., 2011, 8(8), 973-990.
[http://dx.doi.org/10.1517/17425247.2011.581655] [PMID: 21668403]
[http://dx.doi.org/10.1517/17425247.2011.581655] [PMID: 21668403]
[9]
Varoni, E.M.; Lo Faro, A.F.; Sharifi-Rad, J.; Iriti, M. Anticancer molecular mechanisms of resveratrol. Front. Nutr., 2016, 3, 1-15.
[http://dx.doi.org/10.3389/fnut.2016.00008]
[http://dx.doi.org/10.3389/fnut.2016.00008]
[10]
Athar, M.; Back, J.H.; Tang, X.; Kim, K.H.; Kopelovich, L.; Bickers, D.R.; Kim, A.L. Resveratrol: A review of preclinical studies for human cancer prevention. Toxicol. Appl. Pharmacol., 2007, 224(3), 274-283.
[http://dx.doi.org/10.1016/j.taap.2006.12.025] [PMID: 17306316]
[http://dx.doi.org/10.1016/j.taap.2006.12.025] [PMID: 17306316]
[11]
Buhrmann, C.; Shayan, P.; Kraehe, P.; Popper, B.; Goel, A.; Shakibaei, M. Resveratrol induces chemosensitization to 5-fluorouracil through up-regulation of intercellular junctions, Epithelial-to-mesenchymal transition and apoptosis in colorectal cancer. Biochem. Pharmacol., 2015, 98(1), 51-68.
[http://dx.doi.org/10.1016/j.bcp.2015.08.105] [PMID: 26310874]
[http://dx.doi.org/10.1016/j.bcp.2015.08.105] [PMID: 26310874]
[12]
Lee, S.H.; Koo, B.S.; Park, S.Y.; Kim, Y.M. Anti-angiogenic effects of resveratrol in combination with 5-fluorouracil on B16 murine melanoma cells. Mol. Med. Rep., 2015, 12(2), 2777-2783.
[http://dx.doi.org/10.3892/mmr.2015.3675] [PMID: 25936796]
[http://dx.doi.org/10.3892/mmr.2015.3675] [PMID: 25936796]
[13]
Wu, S.L.; Sun, Z.J.; Yu, L.; Meng, K.W.; Qin, X.L.; Pan, C.E. Effect of resveratrol and in combination with 5-FU on murine liver cancer. World J. Gastroenterol., 2004, 10(20), 3048-3052.
[http://dx.doi.org/10.3748/wjg.v10.i20.3048] [PMID: 15378791]
[http://dx.doi.org/10.3748/wjg.v10.i20.3048] [PMID: 15378791]
[14]
Mohan, A.; Narayanan, S.; Sethuraman, S.; Krishnan, U.M. Novel resveratrol and 5-fluorouracil coencapsulated in pegylated nanoliposomes improve chemotherapeutic efficacy of combination against head and neck squamous cell carcinoma. BioMed Res. Int., 2014, 424239, 1-14.
[http://dx.doi.org/10.1155/2014/424239]
[http://dx.doi.org/10.1155/2014/424239]
[15]
Dun, J.; Chen, X.; Gao, H.; Zhang, Y.; Zhang, H.; Zhang, Y. Resveratrol synergistically augments anti-tumor effect of 5-FU in vitro and in vivo by increasing S-phase arrest and tumor apoptosis. Exp. Biol. Med. (Maywood), 2015, 240(12), 1672-1681.
[http://dx.doi.org/10.1177/1535370215573396] [PMID: 25736303]
[http://dx.doi.org/10.1177/1535370215573396] [PMID: 25736303]
[16]
Goindi, S.; Arora, P.; Kumar, N.; Puri, A. Development of novel ionic liquid-based microemulsion formulation for dermal delivery of 5-Fluorouracil. AAPS PharmSciTech, 2014, 15(4), 810-821.
[http://dx.doi.org/10.1208/s12249-014-0103-1] [PMID: 24668136]
[http://dx.doi.org/10.1208/s12249-014-0103-1] [PMID: 24668136]
[17]
Agarwal, A.; Kharb, V.; Saharan, V.A. Process optimisation, characterisation and evaluation of resveratrol-phospholipid complexes using Box-Behnken statistical design. Int. Curr. Pharm. J., 2014, 3, 301-308.
[http://dx.doi.org/10.3329/icpj.v3i7.19079]
[http://dx.doi.org/10.3329/icpj.v3i7.19079]
[18]
de Mattos, A.C.; Khalil, N.M.; Mainardes, R.M. Development and validation of an HPLC method for the determination of fluorouracil in polymeric nanoparticles. Braz. J. Pharm. Sci., 2013, 49, 117-126.
[http://dx.doi.org/10.1590/S1984-82502013000100013]
[http://dx.doi.org/10.1590/S1984-82502013000100013]
[19]
Sinha, V.R.; Kumar, R.V.; Bhinge, J.R. A stability-indicating RP-HPLC assay method for 5-fluorouracil. Indian J. Pharm. Sci., 2009, 71(6), 630-637.
[http://dx.doi.org/10.4103/0250-474X.59544] [PMID: 20376215]
[http://dx.doi.org/10.4103/0250-474X.59544] [PMID: 20376215]
[20]
Cvetkovic, Z.; Nikolic, V.; Savic, I.; Savic-Gajic, I.; Nikolic, L. Development and validation of an RP-HPLC method for quantification of trans-resveratrol in the plant extracts. Hem. Ind., 2015, 69, 679-687.
[http://dx.doi.org/10.2298/HEMIND140917004C]
[http://dx.doi.org/10.2298/HEMIND140917004C]
[21]
Pangeni, R.; Ali, J.; Mustafa, G.; Sharma, S.; Baboota, S. Design expert-supported development and validation of stability indicating high-performance liquid chromatography (HPLC) method for determination of resveratrol in bulk drug and pharmaceutical formulation. Int. J. Pharm. Sci. Res., 2015, 6, 5115-5125.
[22]
Validation of analytical procedures: Text and methodology Q2(R1) International Conference on Harmonization. Available from:. https://www.ema.europa. eu/en/ich-q2-r1-validation-analytical-procedures-text-methodology
[23]
Mohamed, A.I.; Abd-Motagaly, A.M.E.; Ahmed, O.A.A.; Amin, S.; Ali, A.I.M. Investigation of drug-polymer compatibility using
chemometric-assisted UV-spectrophotometry. Pharmaceutics,
2017, 9, 01-13..
[24]
Pani, N.R.; Nath, L.K.; Acharya, S.; Bhuniya, B. Application of DSC, IST, and FTIR study in the compatibility testing of nateglinide with different pharmaceutical excipients. J. Therm. Anal. Calorim., 2012, 108, 219-226.
[http://dx.doi.org/10.1007/s10973-011-1299-x]
[http://dx.doi.org/10.1007/s10973-011-1299-x]
[25]
Chidambaram, M.; Krishnasamy, K. Drug-drug/drug-excipient compatibility studies on curcumin using non-thermal methods. Adv. Pharm. Bull., 2014, 4(3), 309-312.
[PMID: 24754017]
[PMID: 24754017]
[26]
Kumar, S.; Lather, V.; Pandita, D. Stability indicating simplified HPLC method for simultaneous analysis of resveratrol and quercetin in nanoparticles and human plasma. Food Chem., 2016, 197(Pt A), 959-964.,
[http://dx.doi.org/10.1016/j.foodchem.2015.11.078] [PMID: 26617040]
[http://dx.doi.org/10.1016/j.foodchem.2015.11.078] [PMID: 26617040]
[27]
Shah, Y.; Iqbal, Z.; Ahmad, L.; Khan, A.; Khan, M.I.; Nazir, S.; Nasir, F. Simultaneous determination of rosuvastatin and atorvastatin in human serum using RP-HPLC/UV detection: Method development, validation and optimization of various experimental parameters. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2011, 879(9-10), 557-563.
[http://dx.doi.org/10.1016/j.jchromb.2011.01.004] [PMID: 21324753]
[http://dx.doi.org/10.1016/j.jchromb.2011.01.004] [PMID: 21324753]
[28]
Chen, W.; Shen, Y.; Rong, H.; Lei, L.; Guo, S. Development and application of a validated gradient elution HPLC method for simultaneous determination of 5-fluorouracil and paclitaxel in dissolution samples of 5-fluorouracil/paclitaxel-co-eluting stents. J. Pharm. Biomed. Anal., 2012, 59, 179-183.
[http://dx.doi.org/10.1016/j.jpba.2011.10.005] [PMID: 22075374]
[http://dx.doi.org/10.1016/j.jpba.2011.10.005] [PMID: 22075374]
[29]
Baboota, S.; Faiyaz, S.; Ahuja, A.; Ali, J.; Shafiq, S.; Sayeed, A. Development and validation of stability-indicating HPLC method for analysis of Celecoxib (CXB) in bulk drug and microemulsion formulations. Acta Chromatogr., 2007, 18, 116-129.
[30]
Hasan, S.; Chander, P.; Ali, J.; Baboota, S.; Ali, M. A new validated ultra performance liquid chromatographic method for determination of acyclovir. Drug Test. Anal., 2011, 3(3), 187-190.
[http://dx.doi.org/10.1002/dta.201] [PMID: 21038374]
[http://dx.doi.org/10.1002/dta.201] [PMID: 21038374]
[31]
Khan, H.; Ali, M.; Ahmad, S.; Ahmad, N.; Ahuja, A.; Baboota, S.; Ali, J. Validated UPLC/Q-TOF-MS method for simultaneous determination of aceclofenac, paracetamol, and their degradation products in tablets. J. Liq. Chromatogr. Relat. Technol., 2012, 35, 109-128.
[http://dx.doi.org/10.1080/10826076.2011.597063]
[http://dx.doi.org/10.1080/10826076.2011.597063]
[32]
Pinto, E.C.; Gonçalves, M.D.S.; Cabral, L.M.; Armstrong, D.W.; de Sousa, V.P. Development and validation of a stability-indicating HPLC method for topiramate using a mixed-mode column and charged aerosol detector. J. Sep. Sci., 2018, 41(8), 1716-1725.
[http://dx.doi.org/10.1002/jssc.201701340] [PMID: 29288527]
[http://dx.doi.org/10.1002/jssc.201701340] [PMID: 29288527]
[33]
Syed, H.K.; Liew, K.B.; Loh, G.O.K.; Peh, K.K. Stability indicating HPLC-UV method for detection of curcumin in Curcuma longa extract and emulsion formulation. Food Chem., 2015, 170, 321-326.
[http://dx.doi.org/10.1016/j.foodchem.2014.08.066 PMID: 25306352]
[http://dx.doi.org/10.1016/j.foodchem.2014.08.066 PMID: 25306352]
[34]
Beludari, M.I.; Prakash, K.V.; Mohan, G.K. RP-HPLC method for simultaneous estimation of rosuvastatin and ezetimibe from their combination tablet dosage form. Int. J. Chem. Anal. Sci., 2013, 4, 205-209.
[http://dx.doi.org/10.1016/j.ijcas.2013.04.006]
[http://dx.doi.org/10.1016/j.ijcas.2013.04.006]
[35]
Iram, F.; Iram, H.; Iqbal, A.; Husain, A. Forced degradation studies J. Anal. Pharm. Res., 2016, 3, 1-5.
[36]
Imran, M.; Iqubal, M.K.; Ahmad, S.; Ali, J.; Baboota, S. Stability-indicating high-performance thin-layer chromatographic method for the simultaneous determination of quercetin and resveratrol in the lipid-based nanoformulation. JPC-J. Planar Chrom.-. Modern TLC, 2019, 32, 393-400.
[http://dx.doi.org/10.1556/1006.2019.32.5.7]
[http://dx.doi.org/10.1556/1006.2019.32.5.7]
[37]
Khan, S.; Shaharyar, M.; Fazil, M.; Baboota, S.; Ali, J. Tacrolimus-loaded nanostructured lipid carriers for oral delivery - Optimization of production and characterization. Eur. J. Pharm. Biopharm., 2016, 108, 277-288.
[http://dx.doi.org/10.1016/j.ejpb.2016.07.017] [PMID: 27449630]
[http://dx.doi.org/10.1016/j.ejpb.2016.07.017] [PMID: 27449630]
Article Metrics
10
1